Washington, D.C. (April 6, 2020) – America’s Blood Centers and its members are working closely with the U.S. Food and Drug Administration (FDA) to collect and distribute convalescent plasma from individuals who have recovered from COVID-19. “Community blood centers are at the forefront of delivering convalescent plasma to patients in critical need. This promising investigational…
Read More(Washington, DC – March 12, 2020) – “We need people to start turning out in force to give blood.” That urgent call-to-action coming from Peter Marks, M.D., Ph.D., director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research, as fear about the coronavirus is keeping people from wanting to donate…
Read More(Washington, DC – March 10, 2020) Concerns over the coronavirus are negatively impacting the nation’s blood supply and it has blood centers around the country appealing to the public that now is the time to donate. “We are facing a national blood supply issue. As coronavirus fears intensify, blood centers around the country are experiencing…
Read MoreBethesda, Md. – As the coronavirus outbreak continues to spread in the United States, the AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism is urging individuals to make and keep donation appointments and organized blood drives to ensure the continued adequacy of the blood supply. Read complete press release.
Read MoreAmerica’s Blood Centers (ABC) encourages the Food and Drug Administration (FDA) to continue to assess the impact of the Final Guidance issued on Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion Guidance for Industry. While the Final Guidance took an important step…
Read More